Stock data
Abbott Laboratories (ABT)
Abbott Laboratories (ABT) reported revenue of US$44.33B and net income of US$6.52B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$44.33B | — | US$8.05B | US$6.52B | — |
| 2024 | US$41.95B | — | US$6.83B | US$13.40B | — |
| 2023 | US$40.11B | — | US$6.48B | US$5.72B | — |
| 2022 | US$43.65B | — | US$8.36B | US$6.93B | — |
| 2021 | US$43.08B | — | US$8.43B | US$7.07B | — |
Quarterly results
Data as of 2026-03-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-03-31 | US$11.16B | US$1.08B | — |
| 2025-12-31 | US$11.46B | US$1.78B | — |
| 2025-09-30 | US$11.37B | US$1.64B | — |
| 2025-06-30 | US$11.14B | US$1.78B | — |
| 2025-03-31 | US$10.36B | US$1.32B | — |
| 2024-12-31 | US$10.97B | US$9.23B | — |
| 2024-09-30 | US$10.63B | US$1.65B | — |
| 2024-06-30 | US$10.38B | US$1.30B | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.